Idinvest Partners: 7 million Euro Series‑A for TeleCLinic

Cate­gory: Venture Capi­tal
29. Novem­ber 2018

Munich / Frank­furt am Main — Munich-based tele­me­di­cine company Tele­Cli­nic has successfully closed its Series A finan­cing and recei­ved a capi­tal commit­ment of seven million euros from Idin­vest Part­ners to expand its market leader­ship in telemedicine.

Idin­vest Part­ners is a Euro­pean invest­ment company specia­li­zing in the SME segment, with more than eight billion euros in assets under manage­ment, which has alre­ady comple­ted more than 4,000 finan­cings throug­hout Europe. As one of the largest Euro­pean venture capi­tal inves­tors, Idin­vest Part­ners is able to support port­fo­lio compa­nies from seed finan­cing to later finan­cing stages. The company has previously funded digi­tal pioneers such as Allt­hings, Deezer, Wefox and Withings.

Just in Novem­ber 2017, Tele­Cli­nic had closed a seed finan­cing of two million euros. Now the next big step is about to be taken to scale the busi­ness model and provide digi­tal access to medi­cal care for milli­ons more pati­ents. New stra­te­gic part­ner­ships and marke­ting measu­res are plan­ned for this purpose.

Today, 50 percent of all private pati­ents in Germany alre­ady have free digi­tal access to doctors from 30 special­ties thanks to Tele­Cli­nic. The number of people with statu­tory health insu­rance is around nine million. This makes Tele­Cli­nic part of stan­dard care. For private pati­ents, e‑prescriptions are possi­ble throug­hout Germany via Tele­Cli­nic. For this purpose, the company coope­ra­tes with 7,000 phar­macies. Those with statu­tory health insu­rance are to follow suit in 2019 — initi­ally as part of a pilot project. Medi­cal services are available seven days a week, around the clock, and on holidays.

With annual growth of 3.8 percent, the health­care sector is growing signi­fi­cantly faster than the gross dome­stic product (source: BMWI Gesund­heits­wirt­schaft Zahlen und Fakten 2016). The health­care indus­try is thus a growth sector that is not depen­dent on econo­mic cycles. The private sector, for exam­ple medi­cal products or e‑health appli­ca­ti­ons, accounts for 21.3 percent of value added. Tele­me­di­cine is seen as a promi­sing future market.

Katha­rina Jünger (photo) , CEO of Tele­Cli­nicis convin­ced that tele­me­di­cine will play a central role in the German health­care system in the future: “The digi­tiza­tion of the health­care system is curr­ently advan­cing in leaps and bounds. We are actively helping to shape this deve­lo­p­ment and want to use Tele­Cli­nic to ensure digi­tal access to high-quality primary care across the coun­try. Germany needs tele­me­di­cine to effi­ci­ently meet chal­lenges such as demo­gra­phic change. People are getting older and, as a result, spen­ding is rising. Tele­con­sul­ta­tion alone has an esti­ma­ted bene­fit poten­tial of 4.4 billion euros. We are plea­sed to have gained a strong part­ner in Idin­vest Part­ners to digi­tally shape the future of health.”

Matthieu Baret, Mana­ging Part­ner at Idin­vest Part­ners and respon­si­ble for Venture and Growth Capi­tal, said: “Idin­vest Part­ners has made a name for itself as one of the highest-profile venture capi­tal inves­tors in Europe with invest­ments in well-known and successful compa­nies in the digi­tal and health­care indus­tries. The invest­ment in Tele­Cli­nic repres­ents another mile­stone in this stra­tegy. Tele­Cli­nic is a pioneer in a promi­sing busi­ness area and a market with great poten­tial. In an envi­ron­ment of demo­gra­phic change and incre­asing gaps in medi­cal care in rural areas, the company fulfills an important social mission. We are plea­sed to support Tele­Cli­nic in fulfil­ling this mission.”

About Tele­Cli­nic
Tele­Cli­nic is a digi­tal health plat­form and first point of cont­act for people who have ques­ti­ons about their health. The Tele­Cli­nic physi­ci­ans are available for pati­ents seven days a week and at any time of day — without long waiting times. Only physi­ci­ans with a German license to prac­tice medi­cine are admit­ted to Tele­Cli­nic. Medi­cal consul­ta­tion takes place via modern and nowa­days common commu­ni­ca­tion chan­nels. The pati­ent can choose whether the doctor’s conver­sa­tion takes place via video chat or on the phone, for exam­ple. Tele­Cli­nic is also a digi­tal pioneer in the area of e‑prescription: e‑prescriptions have been possi­ble for priva­tely insu­red pati­ents since the begin­ning of 2018. To this end, the company coope­ra­tes with 7,000 phar­macies in private prac­tice. To ensure that pati­ents can use the services of the Tele­Cli­nic free of charge, the company coope­ra­tes with various payers. Curr­ently, eight private health insu­r­ers and four statu­tory health insu­r­ers coope­rate with Tele­Cli­nic. In addi­tion, as part of the coope­ra­tion with the Asso­cia­tion of Statu­tory Health Insu­rance Physi­ci­ans in Baden-Würt­­te­m­­berg, all statu­tory health insu­rance funds in Baden-Würt­­te­m­­berg bear the costs for digi­tal health services via the Tele­Cli­nic infrastructure.

Data secu­rity is a top prio­rity: the Tele­Cli­nic app ther­e­fore complies with the requi­re­ments of the Medi­cal Devices Act for CE certi­fi­ca­tion. TeleClinic’s mission is to deve­lop digi­tal and effi­ci­ent alter­na­ti­ves for the German health­care system that bene­fit pati­ents, insu­rance compa­nies, health insu­r­ers and doctors.

About Idin­vest Partners
Idin­vest Part­ners is a leading Euro­pean invest­ment firm focu­sed on the mid market. Curr­ently, Idin­vest Part­ners mana­ges assets of around €8 billion with more than 90 employees and has offices in Paris, Frank­furt, Madrid, Shang­hai and Dubai. The company has three busi­ness units: Venture & Growth Capi­tal, Private Debt and Private Funds Group. The company was foun­ded in 1997 as part of the Alli­anz Group and has been inde­pen­dent since 2010. In Janu­ary 2018, Idin­vest Part­ners merged with Eura­zeo. The merger has crea­ted a leading invest­ment company in Europe and North America with 15 billion euros in assets under management.

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at]